WallStSmart

Cintas Corporation (CTAS)vsNorthrop Grumman Corporation (NOC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Northrop Grumman Corporation generates 284% more annual revenue ($42.37B vs $11.03B). CTAS leads profitability with a 17.6% profit margin vs 10.8%. CTAS appears more attractively valued with a PEG of 2.77. NOC earns a higher WallStSmart Score of 63/100 (C+).

CTAS

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 9.0Value: 2.7Quality: 7.3
Piotroski: 6/9Altman Z: 4.29

NOC

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTASSignificantly Overvalued (-29.5%)

Margin of Safety

-29.5%

Fair Value

$154.77

Current Price

$173.95

$19.18 premium

UndervaluedFair: $154.77Overvalued
NOCSignificantly Overvalued (-61.6%)

Margin of Safety

-61.6%

Fair Value

$419.98

Current Price

$579.48

$159.50 premium

UndervaluedFair: $419.98Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
41.3%10/10

Every $100 of equity generates 41 in profit

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$69.90B9/10

Large-cap with strong market position

Operating MarginProfitability
23.2%8/10

Strong operational efficiency at 23.2%

NOC3 strengths · Avg: 9.3/10
EPS GrowthGrowth
84.9%10/10

Earnings expanding 84.9% YoY

Market CapQuality
$82.31B9/10

Large-cap with strong market position

Return on EquityProfitability
28.5%9/10

Every $100 of equity generates 29 in profit

Areas to Watch

CTAS3 concerns · Avg: 3.3/10
P/E RatioValuation
36.9x4/10

Premium valuation, high expectations priced in

Price/BookValuation
14.5x4/10

Trading at 14.5x book value

PEG RatioValuation
2.772/10

Expensive relative to growth rate

NOC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Debt/EquityHealth
1.183/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.6% and operating margin at 23.2%.

Bull Case : NOC

The strongest argument for NOC centers on EPS Growth, Market Cap, Return on Equity.

Bear Case : CTAS

The primary concerns for CTAS are P/E Ratio, Price/Book, PEG Ratio.

Bear Case : NOC

The primary concerns for NOC are Revenue Growth, Altman Z-Score, Debt/Equity.

Key Dynamics to Monitor

CTAS profiles as a mature stock while NOC is a value play — different risk/reward profiles.

CTAS carries more volatility with a beta of 1.01 — expect wider price swings.

CTAS is growing revenue faster at 8.9% — sustainability is the question.

CTAS generates stronger free cash flow (531M), providing more financial flexibility.

Bottom Line

NOC scores higher overall (63/100 vs 58/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Northrop Grumman Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Northrop Grumman Corporation (NYSE: NOC) is an American multinational aerospace and defense technology company.

Visit Website →

Want to dig deeper into these stocks?